Klp Kapitalforvaltning As Eye Point Pharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 7,900 shares of EYPT stock, worth $49,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,900Holding current value
$49,533% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
152Shares Held
59.5MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$52.2 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$32.5 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$25.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$23.8 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $214M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...